標(biāo)題: Titlebook: Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune; A. M. Diehl,N. Hayashi,T. Sauerbruch Book Sep 20071st edition Springer Sc [打印本頁(yè)] 作者: malcontented 時(shí)間: 2025-3-21 19:10
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune影響因子(影響力)
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune被引頻次
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune被引頻次學(xué)科排名
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune年度引用
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune年度引用學(xué)科排名
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune讀者反饋
書(shū)目名稱(chēng)Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune讀者反饋學(xué)科排名
作者: 金桌活畫(huà)面 時(shí)間: 2025-3-21 21:46 作者: 責(zé)問(wèn) 時(shí)間: 2025-3-22 03:14 作者: magnate 時(shí)間: 2025-3-22 04:40
Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune作者: 令人發(fā)膩 時(shí)間: 2025-3-22 11:07 作者: 坦白 時(shí)間: 2025-3-22 14:42
c level.This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developmen作者: 坦白 時(shí)間: 2025-3-22 17:49
Ralph-Johan Back,Joakim von Wrightof intermediate severity, characterized by overt injury and death of fatty hepatocytes. NASH may incite a sufficient fibrotic response to eventuate in cirrhosis. Hepatocellular carcinoma sometimes develops in cirrhotic livers.作者: Narcissist 時(shí)間: 2025-3-22 23:11
https://doi.org/10.1007/978-3-319-61599-8ic any form of acute or chronic liver disease; (4) it is the leading cause of failure in drug development and warning and withdrawls postmarketing. In this chapter I will concisely address some of the key clinical and pathophysiological points about DILI.作者: 密切關(guān)系 時(shí)間: 2025-3-23 03:56
Data Refinement and Simulations Many new HCV drugs are at the preclinical developmental schematically belong to four categores: novel IFN, alternatives to ribavirin, immune therapies, and specific and non-specific inhibitors of the HCV life cycle.作者: 厭倦嗎你 時(shí)間: 2025-3-23 08:11
John Derrick BSc, DPhil,Eerke Boiten Ir, PhDS are rare, nobody has ample experience with respect to characterization, diagnosis and treatment. This means that the following data are based on investigations performed in small patient numbers only, and the picture may change when more information becomes available.作者: 隱語(yǔ) 時(shí)間: 2025-3-23 10:19
Refinements of the Nash Equilibrium Concept changes that have taken place since my somewhat ‘nerve wracking’ experience as a young intern. In those days management of chronic liver disease was nearly always for an acute change in someone with a previously unrecognized, often silent, chronic condition.作者: 無(wú)價(jià)值 時(shí)間: 2025-3-23 17:56
A Hands-on Guide to Confocal Imaginglogical renal lesions) associated with terminal hepatic insufficiency due to intense splanchnic arterial vasodilation and severe impairment in circulatory function (peripheral arterial vasodilation hypothesis).作者: 迷住 時(shí)間: 2025-3-23 21:08 作者: 乏味 時(shí)間: 2025-3-23 22:25
Drug-induced Hepatitisic any form of acute or chronic liver disease; (4) it is the leading cause of failure in drug development and warning and withdrawls postmarketing. In this chapter I will concisely address some of the key clinical and pathophysiological points about DILI.作者: 施魔法 時(shí)間: 2025-3-24 03:32 作者: BYRE 時(shí)間: 2025-3-24 10:28
Overlap SyndromesS are rare, nobody has ample experience with respect to characterization, diagnosis and treatment. This means that the following data are based on investigations performed in small patient numbers only, and the picture may change when more information becomes available.作者: 思考而得 時(shí)間: 2025-3-24 13:42 作者: 嚴(yán)厲批評(píng) 時(shí)間: 2025-3-24 15:27
Advances in the pathogenesis and treatment of type 1 and type 2 heapatorenal Syndromelogical renal lesions) associated with terminal hepatic insufficiency due to intense splanchnic arterial vasodilation and severe impairment in circulatory function (peripheral arterial vasodilation hypothesis).作者: braggadocio 時(shí)間: 2025-3-24 21:57
Data Refinement and Simulations self-limiting infection and could not yet establish a chronic carrier state. After a non-specific uptake of hepadnavirus genomes, later steps in the viral life cycle are not strictly host-restricted, as is shown by transgenic HBV-producing mice.作者: Armada 時(shí)間: 2025-3-25 00:35
Pathobiology of hepatitis B virus infection self-limiting infection and could not yet establish a chronic carrier state. After a non-specific uptake of hepadnavirus genomes, later steps in the viral life cycle are not strictly host-restricted, as is shown by transgenic HBV-producing mice.作者: obligation 時(shí)間: 2025-3-25 05:55
https://doi.org/10.1007/978-3-319-61599-8nly 10–20% progress to liver cirrhosis. It has been speculated that genetic aspects may play a predominant role, explaining why not every alcoholix develops advanced liver disease. Although polymorphisms of genes involved in alcoholic liver disease (ALD) have been intensively studied, the results so far are disappointing.作者: 心痛 時(shí)間: 2025-3-25 10:47 作者: Yourself 時(shí)間: 2025-3-25 13:36 作者: ethereal 時(shí)間: 2025-3-25 18:19
Falk Symposiumhttp://image.papertrans.cn/c/image/226378.jpg作者: 廢止 時(shí)間: 2025-3-25 20:30
Ralph-Johan Back,Joakim von Wrighttrum) to cirrhosis (on the opposite extreme where most liver-related morbidity and mortality occur). Non-alcoholic steatohepatitis (NASH) is a lesion of intermediate severity, characterized by overt injury and death of fatty hepatocytes. NASH may incite a sufficient fibrotic response to eventuate in作者: dowagers-hump 時(shí)間: 2025-3-26 00:27
https://doi.org/10.1007/978-3-319-61599-8ohol misuse or dependence. Similar data exist for some countries in Europe, including Germany, where more than 1.5 million individuals are alcohol-dependent and approximately 3 milllion people have alcohol-associated organ damage. Chronic alcohol consumption above a certain daily threshold results i作者: 冰雹 時(shí)間: 2025-3-26 04:43 作者: 小母馬 時(shí)間: 2025-3-26 11:33
A Tutorial Introduction to CSP in , ,er delivery: spider angimas, palmar erythema, elevated alkaline phosphatase due to placental production, increased plasma volume by approximately 50%, hypoalbuminaemia. An increase in serum aminotransferase, bilirubin, or fasting total bile acid concentrations during pregnancy is pathological and sh作者: 急急忙忙 時(shí)間: 2025-3-26 16:17
Lecture Notes in Computer Sciencetrahepatic bile ducts. It eventually leads to liver cirrhosid and failure over a period of time that can vary widely among patients. The only treatments currently accepted are lifelong therapy with ursodeoxycholic acid (UDCA) and liver transplantation.作者: 草率女 時(shí)間: 2025-3-26 19:33
Case Study: A Digital and Analogue Watchays having in common an interface hepatitis. One is the so-called biliary or ductular piecemeal necrosis (PMN). In contrast, in other patients the progression seems to result by the same mechanisms as in chronic viral hepatitis or as in autoimmune hepatitis (AIH). They show the typical features of l作者: 使殘廢 時(shí)間: 2025-3-26 21:39 作者: 職業(yè) 時(shí)間: 2025-3-27 04:31 作者: 你不公正 時(shí)間: 2025-3-27 07:17 作者: Eructation 時(shí)間: 2025-3-27 12:49 作者: 違抗 時(shí)間: 2025-3-27 16:18 作者: 國(guó)家明智 時(shí)間: 2025-3-27 20:00 作者: 谷類(lèi) 時(shí)間: 2025-3-28 01:58 作者: adulterant 時(shí)間: 2025-3-28 04:41 作者: infarct 時(shí)間: 2025-3-28 07:34 作者: Limpid 時(shí)間: 2025-3-28 13:55 作者: lactic 時(shí)間: 2025-3-28 15:49
Case Study: A Digital and Analogue Watchays having in common an interface hepatitis. One is the so-called biliary or ductular piecemeal necrosis (PMN). In contrast, in other patients the progression seems to result by the same mechanisms as in chronic viral hepatitis or as in autoimmune hepatitis (AIH). They show the typical features of lymphocyctic PMN.作者: 保守黨 時(shí)間: 2025-3-28 20:41
Data Refinement and Simulations In Western countries, genotypes 1, 2, and 3 are primarily found, with a predominance of genotype 1. Genotype 4 is widely distributed in North Africa and the Middle East, whereas genotype 5 is found in South Africal, and genotype 6 in Hong Kong and more recently in Australia.作者: 儀式 時(shí)間: 2025-3-28 23:36 作者: 和平主義者 時(shí)間: 2025-3-29 05:33
https://doi.org/10.1007/978-3-642-31884-9he wedged hepatic venous pressure and the free hepatic venous pressure (HVPG). This gradient reflects rather adequeately the portal pressure requires an invasive percutaneous transhepatic approach or intraoperative puncture of the portal veint. Measurement of the portal flow is not an adequate substitute for HVPG.作者: Defraud 時(shí)間: 2025-3-29 08:15
https://doi.org/10.1007/978-1-4020-6523-1apoptosis; hepatitis; hepatitis B; hepatology; immunosuppression; infection; liver; liver disease; liver tra作者: LAP 時(shí)間: 2025-3-29 11:34 作者: Adulterate 時(shí)間: 2025-3-29 17:10 作者: 遺傳 時(shí)間: 2025-3-29 22:53 作者: Badger 時(shí)間: 2025-3-30 03:31 作者: Fortuitous 時(shí)間: 2025-3-30 05:38 作者: garrulous 時(shí)間: 2025-3-30 11:16 作者: Nonthreatening 時(shí)間: 2025-3-30 16:04 作者: Precursor 時(shí)間: 2025-3-30 19:05 作者: 繼承人 時(shí)間: 2025-3-30 22:09 作者: 丑惡 時(shí)間: 2025-3-31 02:15
Management of ascites and spontaneous bacterial peritonitisAscites is defined as the accumulation of free fluid in the peritoneal cavity. This entity was first described by the ancient Egyptians and Greeks. Erasitratus of Cappadoccia, in 300 BC, noted the relationship between hardness of the liver and ascites.作者: Intuitive 時(shí)間: 2025-3-31 07:05 作者: indices 時(shí)間: 2025-3-31 13:10 作者: 字形刻痕 時(shí)間: 2025-3-31 16:58
Geoepidemiology of primary billary cirrhosistrahepatic bile ducts. It eventually leads to liver cirrhosid and failure over a period of time that can vary widely among patients. The only treatments currently accepted are lifelong therapy with ursodeoxycholic acid (UDCA) and liver transplantation.作者: Dri727 時(shí)間: 2025-3-31 21:22 作者: 高原 時(shí)間: 2025-4-1 00:48 作者: 迫擊炮 時(shí)間: 2025-4-1 04:08 作者: AGONY 時(shí)間: 2025-4-1 06:09
Treatment of Portal Hypertension and variceal bleedinghe wedged hepatic venous pressure and the free hepatic venous pressure (HVPG). This gradient reflects rather adequeately the portal pressure requires an invasive percutaneous transhepatic approach or intraoperative puncture of the portal veint. Measurement of the portal flow is not an adequate substitute for HVPG.作者: Forage飼料 時(shí)間: 2025-4-1 13:15
Nash: Bench to bedside - lessons from animal Modelstrum) to cirrhosis (on the opposite extreme where most liver-related morbidity and mortality occur). Non-alcoholic steatohepatitis (NASH) is a lesion of intermediate severity, characterized by overt injury and death of fatty hepatocytes. NASH may incite a sufficient fibrotic response to eventuate in作者: tenosynovitis 時(shí)間: 2025-4-1 18:03 作者: apropos 時(shí)間: 2025-4-1 19:28 作者: hedonic 時(shí)間: 2025-4-1 23:28 作者: Catheter 時(shí)間: 2025-4-2 06:34
Geoepidemiology of primary billary cirrhosistrahepatic bile ducts. It eventually leads to liver cirrhosid and failure over a period of time that can vary widely among patients. The only treatments currently accepted are lifelong therapy with ursodeoxycholic acid (UDCA) and liver transplantation.作者: 黃瓜 時(shí)間: 2025-4-2 08:57
Interface Hepatitis in primary billary cirrhosis prognostic marker and therapeutic targetays having in common an interface hepatitis. One is the so-called biliary or ductular piecemeal necrosis (PMN). In contrast, in other patients the progression seems to result by the same mechanisms as in chronic viral hepatitis or as in autoimmune hepatitis (AIH). They show the typical features of l作者: fulmination 時(shí)間: 2025-4-2 13:36
